LINC00852 and osteosarcoma: As shown by the growth curve of the xenograft tumors, the tumor volume of linc00852 overexpressed group was three times bigger than that of the control group, which indicated that linc00852 overexpression also increased the osteosarcoma cells’ growth and invasion in vivo (Figure 3H,I; P = .000).